Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v6-EN
Language French English
Date Updated 2019-08-01 2019-05-17
Drug Identification Number 02424983 02424983
Brand name SEPTA-LOSARTAN SEPTA-LOSARTAN
Common or Proper name Losartan Losartan
Company Name SEPTA PHARMACEUTICALS INC SEPTA PHARMACEUTICALS INC
Ingredients LOSARTAN POTASSIUM LOSARTAN POTASSIUM
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100s 100s
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2019-01-03 2019-01-03
Estimated end date 2019-12-31 2019-07-31
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Supply issue Supply issue
Health Canada comments